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State of the Art in European Addictions Nursing:  
Perspectives from the UK, Ireland, and The Netherlands 
 
Addiction nursing as a ‘specialist’ nursing role in Europe, similar to other parts of the world, is in an 
‘embryonic’ stage of development. Whilst there is a long and rich history of nurses working with 
individuals, families and communities impacted by problematic substance use, the European nursing 
community has, as yet, to establish a recognized framework for training, certification, standards and 
scope of practice in this field.  If we are to safeguard and amplify the important role and contribution 
that nursing can make to this growing public health concern, there is a need to urgently tackle this 
status quo.  As part of this response a group of European nurses, many of whom have been tirelessly 
working to change things in their respective countries, established the International Nurses Society in 
Addictions Nursing (IntNSA) European Region at the 10th ICN Nurse Practitioner and Advanced Practice 
Nurses Congress in Rotterdam, in August 2018.   Nursing by its nature is about commitment to change 
things for the better, this effort and motivation has never been more needed and by doing it together 
the possibilities are endless.  
 
Nature and Scale of the Problem across Europe  
 
Established in 1993 the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) collates 
and publishes detailed information on drug use and drug markets from over 30 European countries, 
and publishes a partial overview of the drug situation in 16 other countries (EMCDDA, 2018a). Data 
gathered annually provide governments and policy makers with comprehensive information on drug 
related trends which are used to inform laws and public health strategies. In addition to providing this 
information, the EMCDDA also seeks to provide the best evidence to ensure quality assurance and 
adherence to best principles in the prevention, treatment, harm reduction and social integration and 
recovery of drug users (EMCDDA, 2017b). In Europe 92 million people have reported having tried at 
least one illicit drug in their lifetime and there are over 1.2 million people in formal treatment for illicit 
drug use (EMCDDA, 2018b). The World Health Organization (WHO, 2018) also identify Europe as 
having the highest per capita alcohol consumption of the five WHO regions, and note alcohol 
consumption as a particular challenge in eastern European countries.  In addition to an ageing 
population of opiate users, there are emerging needs among migrant and asylum-seeking groups. As 
a result of wars in the Middle East and extreme poverty in Africa, Europe saw a migration of 1.4 million 
asylum seekers between 2015-2016, presenting to services with trauma related conditions (e.g. PTSD, 
human trafficking) leaving them susceptible to developing addictions as part of an overall 
 
 
response/coping strategy (Parliament, 2017).  Furthermore, up to 80% of the population who access 
mental health services in Europe  have some form of co-morbid addiction (EMCDDA, 2017a) and we 
are seeing an increasing role for nurses in dealing with behavioural addictions such as gaming, 
gambling and sex addictions, alongside working with families of those affected by addictions (Loth, 
Slee, & Peppel van de, 2012). 
 
Now more than ever the need and demand for specialist competencies that nurses bring to alcohol 
and drug treatment warrants commentary.  What is known is that there are an estimated 7.1 million 
nurses and midwives in the WHO European Region, over 90% are female, and salaries are below the 
national average in many countries. Standardized professional education and preparation for nurses 
has not yet been achieved, however most countries require 12 years of education before entry into 
an educational nursing or midwifery programme.   Many countries recognize the need and are calling 
for nursing prequalifying preparation to move to graduate level education, but there are still countries 
where nurse training is at the level of a vocational qualification.  Although the practice of nursing 
continues to evolve in response to new evidence-based treatments and changing technology, the 
disparity in scope of nursing practice persists, particularly when it comes to standardizing or describing 
advanced or specialist addiction nursing practice.   For a full account on the situation of nursing and 
midwifery in general in the Member States of the European Region check out the following World 
Health Organisation report 1.  Despite these differences, nurses, as the single largest health 
professional group in Europe, are recognized as playing a vital role in assisting society to tackle public 
health challenges, including drug and alcohol use, with or without co-morbid mental health 
conditions, as part of achieving the goals of Health 20202 (see Figure 1).  
 
 
Insert Figure 1 here  
 
By historical standards, problematic substance use is going through a particularly dynamic phase in 
Europe and data suggest that drug availability by international standards is high and increasing  
(EMCDDA, 2018b). In this context, a multitude of factors have contributed to higher rates of drug 
related deaths in some areas (Bellerose, Carew, & Lyons, 2011; Public Health England, 2016). Within 
                                                 









the illicit market, the increased availability of high potency synthetic drugs such as fentanyl, 
cannabinoids, and ecstasy as well as a range of new psychoactive substances has significantly 
increased the risks of drug use (EMCDDA, 2018b). The risk profile of people who are dependent on 
opiates is identified as having a linear relationship with the rising age profile and increases in poly drug 
and alcohol use. Within the general population in The Netherlands, UK and Ireland, prescription rates 
for narcotic analgesics and anxiolytic type drugs have seen a significant increase in the last ten years 
(Gallagher, 2018; Mordecai, Reynolds, Donaldson, & de C Williams, 2018; Van Amsterdam, 
Wartenberg, & Van Den Brink, 2015). While prescribing practices and overall monitoring is different 
from the USA, continuing vigilance is required in this area. The effects of the recent economic 
recession in the UK and Ireland, and the consequential rationalisation of services and cutbacks in the 
number of registered professional staff including specialist nurses, cannot be underestimated or 
ignored in terms of overall negative impact (Kelly, Hegarty, Barry, Dyer, & Horgan, 2018; Middleton, 
McGrail, & Stringer, 2016; Public Health England, 2016).  Conversely, in the Netherlands, the value of 
the addictions nurses prepared at master’s level is increasing and this role is being demanded by 
services.  This need is being driven by the shortage of psychiatrists, a consequence of policy decisions 
to limit the number of training positions for psychiatrists, leaving an opening for nursing specialist 
roles to fill this vacuum (C.Loth, personal communication, October 1, 2018). 
 
Nature and scale across UK, Ireland and The Netherlands 
Based on data from the EMCDDA and the World Health Organisation, Table 1 provides a snapshot of 
the prevalence of opioid use and alcohol use across the three countries: UK, Ireland, and the 
Netherlands. It is notable that the prevalence of opioid use, drug related deaths, HIV transmission and 
some alcohol related harms is significantly higher per capita in Ireland and the UK, than it is in the 
Netherlands. The specific reasons for this are not clear, but historically there have been differences in 
policies in each country. For example, The Netherlands has one of the most liberal drugs policies in 
Europe and has historically placed greater emphasis on harm minimisation models. For example, in 
1976 The Dutch opium law based on a ‘risk scale’ of sociological, pharmacological and psychological 
data, specifically separated ‘hard’ and ‘soft’ drugs, which eventually enabled cannabis to be sold 
legally in ‘coffeeshops’3. The Netherlands has also provided medically supervised safe injecting centres 
in several regions for some time while Ireland and the UK have yet to reach consensus on this 
objective. Anecdotally at least, it is also easier for service users to access prescribed injectable 
diamorphine or methadone in The Netherlands. While both Ireland and the UK have expansive 
                                                 
3 In the Netherlands the term coffee shop has come to mean alcohol-free establishments where cannabis (weed, hash, 




methadone and needle exchange programmes, it is unclear if access to these is more advantageous 
in The Netherlands.  Certainly, prescriptions for injectable diamorphine or methadone are available, 
albeit limited, in the UK, compared with Ireland where this practice is not supported.  While per capita 
alcohol consumption in The Netherlands is almost as high as the UK and Ireland, alcohol related 
disorders, and death rates attributable to liver cirrhosis are significantly lower (WHO, 2018). It is not 
clear whether this is related to different drinking patterns, the number of abstinent drinkers in the 
population, or screening and detection rates for problematic alcohol use. These are all factors worthy 
of further investigation. 
 
 
Insert Table 1 here  
 
Responses to Addiction Treatment within the three countries 
In general, medical treatment is free ‘at the point of access within the UK via the national health 
service (NHS), which the majority of citizens access.  Private medical insurance is also available, should 
individuals opt to pay, which is considered to offer choice of doctor, and a more rapid response (i.e. 
no waiting lists).   In Ireland healthcare is government funded, it is provided by a mix of public and 
private providers and users of the public system are often asked to pay a nominal fee.  Despite this, 
over half of the population has private insurance as this facilitates access to better healthcare.  In the 
Netherlands healthcare is provided by not-for-profit and profit institutions.  All Dutch individuals have 
healthcare insurance – which is covered by the private healthcare insurance companies.  If a person 
cannot afford these payments, social services provide support.    
 
All three countries have published a national drug strategy each of which recognises the importance 
of providing a diverse range of treatment models and optimising access as central to successful long-
term recovery.  Emphasis is also placed on the value of empowering clients as they move through the 
treatment journey towards full reintegration within society.   Of note is that both Ireland and the 
Netherlands have integrated alcohol within their overall strategy, unlike the UK who has published a 
independent strategy for alcohol.   
Responsibility for the co-ordination of addiction care is largely ‘de centralised’ and delegated to 
regional (or national in the case of the UK) and local authorities or publicly funded agencies.  Although 
historically addiction treatment fell within the remit of mental health services, and whilst still broadly 
 
 
attached to the mental healthcare agenda in the Netherlands, addiction is viewed as ‘separate’ in 
terms of health care planning and service provision.   
All three countries describe provision of drug treatment being available across a range of services.  
The Netherlands offers treatment via specialised addiction care organisations; municipal public health 
services, general psychiatric hospitals, several religious organisations and some private clinics.  In the 
UK provision is provided via specialised drug treatment agencies which includes a mix of 
commissioned ‘third-sector organisations’ (i.e. registered charities) and/or in partnership with 
‘statutory (NHS type services). Residential inpatient treatment is available but limited, and if required 
treatment can be offered within prisons. The co ordination and management of Irelands drug 
treatment services comes under the remit of the Primary Care Division, which oversees a number of 
national care groups. Drug treatment is provided through a network of Health Service Executive (HSE) 
services (public), but also non-statutory/voluntary agencies, many of which are funded by the HSE. 
Some private organisations also provide treatment.   Access to a complete overview by all EMCDDA 
reporting countries on the drug situation covering drug supply, use and public health problems as well 
as drug policy and responses is provided via the European Drug Report4 .   
 
 
Role of the Addictions Nurse: overview across three countries  
 
A narrative approach can help our perception of context and description of the emergent ‘specialist’ 
role of the addictions nurse, when considered in parallel with the history and account of drug and 
alcohol treatment within each country.   
 
Ireland   
 
Illicit drugs did not become widely available in Ireland until the late 1960’s and possibly later in many 
areas, but alcohol dependency was widespread and was historically treated through the mental health 
system, where mental health nurses had a key role (Butler, 2014). The development of addiction 
nursing in Ireland, has not been well documented thus far but may be best understood through a 
description of Irish policy responses to drug and alcohol use.  
 
For both historical and political reasons, there has been a long history of a provision of healthcare in 
Ireland by the voluntary and private sector, especially by Catholic Church run organizations, many of 
whom worked in direct opposition to a medical model of recovery. This, amongst other influences, 





has determined the current shape of services in Ireland (Butler & Mayock, 2005; Quin, 2005). The 
earliest addiction rehabilitation programs in Ireland form the 1970’s onwards were largely run by 
members of the Catholic order and were heavily influenced by the disease model of addiction or 
‘Minnesota model’ and were abstinence based while utilizing a confrontational counselling and 
education approach (Butler, 2011). This, in combination with the insurance industry, the role of private 
medicine and government policy have influenced the development of all health services in Ireland 
(Barrington, 1987,p285). Many treatment programs in Ireland were financed, and still are today, by a 
combination of public finance, private health insurance, direct service user payment and public fund 
raising (Butler, 2011). This has somewhat limited government leverage over, and responsibility for, 
addiction treatment services and the development of the workforce.  
 
One of the implications of a historical and ideological opposition to the medical model and church 
involvement has been a strong emphasis on the role of counsellors in addiction treatment services 
(Butler, 2011). In this context, there is evidence of mental health nurses re-training as addiction 
counsellors and under the supervision of non-specialist nurses, taking up roles as counsellors in mental 
health services where their broad range of nursing skills were no longer utilized although this practice 
has now been phased out (Butler, 2011, 2014).  
 
The emergence of the nursing specialism in addictions was still embryonic during the opioid epidemic 
in the capital Dublin in the 1980’s when specialists in addiction nursing began to emerge. This occurred 
in conjunction with the development of a range of government funded services (Scully, Geoghegan, 
Corcoran, Tiernan, & Keenan, 2004). Substitute prescribing services at this time were provided mainly 
in Dublin, under the health services mental health division. The situation in Ireland at that time was 
reflective of other jurisdictions, where there was an overwhelming concern to prevent the spread of 
HIV. During this period, it seems that the role of the nurse initially at least, was confined to the 
dispensing of methadone, without any deference to the much broader nursing skillset. This began to 
change with the publication of a new Irish policy document ‘Psychiatric Services: Planning for the 
future’ (Department of Health, 1984). This sought to move the treatment of addiction problems into 
the community, and attributed addiction to a range of social and health problems which largely 
discredited the disease model of alcoholism (Butler, 2014). This, and the expansion of methadone 
prescribing, and the provision of needle exchanges marked this period where Irish treatment provision 




The most controversial and significant policy shift of recent times, and a most important shift for 
nurses and the medical profession, occurred with the publication of the existing mental health policy 
‘A Vision for Change’ (Department of Health and Children, 2006). This policy determined that people 
with addiction problems would no longer be treated within the mental health system apart from those 
with a co-occurring mental health problem and substance dependence. This policy, in conjunction 
with the publication of the National Service Plan for the National Health Service (Health Service 
Executive, 2005) saw responsibility for addiction treatment shared between the social inclusion and 
primary care directorates (National Documentation Centre on Drug Use, 2005). This policy shift drew 
much criticism from clinicians at this time  and no evidence based justification for the dislocation of 
addiction from the mental health services has ever been provided (Butler, 2014). The implications of 
this policy for addiction nursing have been significant. Many of the statutory services in Dublin with a 
cohort of nurse specialists were retained, but as the opiate problem spread outside of Dublin, service 
provision was typically outsourced voluntary sector providers. This has had implications for nurses in 
many ways. Clinical governance, renumeration, stability of employment as well as career pathways 
for specialist nurses are a continuing source of concern.  
 
There is a growing recognition of the role that specialist nurses can play in addictions and addiction 
nurses continue to provide leadership in developing services, research and initiatives such as the 
implementation of a national brief interventions programme for alcohol (O’Shea & Goff, 2009). Table 
3 provides an overview of the extensive areas in which specialist addiction nurses work in Ireland. In 
2016, The Ireland Chapter of IntNSA was established as IntNSA’s first international chapter and now 
has 53 members. This group formally inputted into the development of Irelands new national drugs 
strategy, which was a first for a specialist nursing group.  This strategy signaled a more pragmatic 
health based approach to drug use, which is reflective of the broader social changes and shifting 
attitudes in Irish society (Department of Health, 2017). Since 2017, addiction nurses are also formally 
represented for the first time at a national level as IntNSA received ministerial invites to sit on The 
National Oversight Committee and The National Implementation Committee which oversee the 
implementation of the new national drug strategy. The strategy specifically mentions the 
development of the nursing role for treating young people, in midwifery and in substitute prescribing 
(Department of Health, 2017).  More broadly, the de-criminilsation of drugs is now being openly 
debated, while the opening of Irelands first medically supervised safe injecting centre in Dublin, which 
will be managed and staffed by nurses, is now imminent.  In 2018, Ireland saw developed its first 
Advanced Nurse Practitioner in addictions and many nurses now prescribe medications albeit in a 
limited capacity. It is hoped that that the work of IntNSA nurses in Ireland supported by international 
 
 
networks, will facilitate the full realisation of the potential benefit for service users of the expansion 




Unsurprisingly when tracking the development of addictions nursing in the Netherlands, the influence 
of how addiction treatment was viewed historically offers insight.  From 1880 till early 1900 addiction 
was seen as reprehensible behavior that must be managed through strict re-education (1880-1920).  
This definition progressed, and addiction was re described as weak behavior treatable by psychological 
interventions aimed at motivational growth (1920-1990), and subsequently this moved to a psychiatric 
disease with chronic aspects treated with the help of medication, cognitive behavioral therapy, and 
cognitive enhancement methods. More latterly attention to the relation between addiction and other 
psychiatric diseases is noted (Blok, 2011). This definition paradigm shift is considered to have a 
tremendous influence on the development of addictions nursing, especially the positionality of the 
nurse within the treatments being offered. For example, the role of the nurse changed from a minor 
role associated with dispensing medication, compared with the social worker who took the ‘treatment 
lead’ to more nurse driven treatment modalities (Loth, 2009). This paradigm shift, alongside a move 
away from expecting clients to achieve total abstinence to accepting harm minimisation, facilitated 
nurses to assert their role and competencies by making nursing work more visible and offered 
opportunities for nurses to demonstrate their value in addressing the spectrum of associated 
challenges particularly how nurses can work with impulsive-compulsive behaviors (Loth, 2009). This 
shift was accompanied by a parallel change in the title given to nurses working in the drug and alcohol 
field i.e. from alcohol and drug nurse to addictions nurse (post bachelor) and addictions specialist 
nurse (master/MANP level), in Dutch ‘verslavingsverpleegkundige’, meaning ‘addictions nurse’. The 
focus is not only substances but also addictive behaviours e.g.  eating disorders, gaming, etc.  The 
roles, tasks and responsibilities of the ‘verslavingsverpleegkundige’ are formalized in legal frameworks 
and are aligned with physicians and psychiatrists. Dutch MANPs are permitted and qualified to 
prescribe anti-craving medication, and medication for detoxification; and are free to consult with 
addictions physicians or addictions psychiatrists concerning off label medications such as topiramate, 
baclofen etc. 
 
Over the last number of years a number of addiction nurses had formed a ‘special interest group’ 
Dutch Society on Addictions Nursing which was formally merged and established as IntNSA Holland, 
and launched in 2018 (www.intnsaholland.com).  This group has been extremely active over the last 
15 years in influencing the addiction agenda within the Netherlands, including connecting and 
 
 
collaborating with the Dutch Society on Addictions Medicine (https://www.vvgn.nl) and other 
institutes concerning addictions treatment and research. The impact of this work has resulted in an 
increase in nursing content in national guidelines concerning relapse management in alcohol 
addiction, methadone maintenance treatment, heroin assisted treatment, and user rooms for alcohol 
and heroin.  
 
In recent years, attention to nursing addiction education has seen the introduction of addictions and 
addictions treatment curricula, including ‘dual diagnosis/co-morbidity’ within the 3-year ANP Mental 
Health nurses training programme.  It is proposed that this curricula provides a strong starting point 
for the development of a European CARN Advanced Nursing Practice award.  
 
Addictions nursing research is increasingly better organized and recognized. In the latter part of the 
20th Century and early 21st Century Loth initiated (Loth, 2009; Loth, Schippers, Hart, & Van De 
Wijngaart, 2007) a change project with employing action research methodology addressing 
methadone maintenance in Holland. This work offered a critical account of poor care facilities and 
poor care by managers, nurses, and those that commission such services. The findings from this 
research were picked up by the National Health Inspectorate who responded by calling for action, 
which led to establishment of the Dutch National guidelines for Methadone Maintenance Treatment 
(including Suboxone, and heroin assisted treatment). This study also offered an opportunity to 
highlight and promote the role of nurses, enhance their autonomy and to take reassert their nursing 
position within this field.  Mumba and Snow (2017) discuss nurse driven treatment options like SBIRT 
and efforts to disseminate such practice was trialed in a general hospital setting in central Holland 
(Tijmensen, van Etten & Loth, 2014). Two ANP nurses implemented alcohol and drug screening during 
admission on the Emergency Room (ER) units and offering clients who screened positive an 
opportunity to undergo brief intervention and/or enter treatment.  The findings from this nurse driven 
research report that patients with Substance Use Disorders (SUD) in general hospitals have to deal 
with negative stigma, poor assessments, and poor treatment options. In addition, the study found that 
hospital staff had a poor image of the work of the addictions specialist nurse.  
 
MANP’s in Holland play an active and advanced role in a range of innovations in addiction treatment, 
for example in developing outpatient clinics for patients suffering from ADHD and SUD.  Including 
developing ‘dual diagnosis’ treatment for patients suffering from SUD and autism spectrum disorders 
and or attentions deficit disorders (Kronenberg, Slager-Visscher, Goossens, van den Brink, & van 
Achterberg, 2014; Kronenberg, Verkerk-Tamminga, Goossens, van den Brink, & van Achterberg, 2015). 
 
 
Furthermore, attention has been given to the special care needs for patients suffering from addictions 
and severe physical problems and end of life care.  A national guideline for palliative care for these 
patients has been developed via practice driven research in collaboration with an addiction institute 
and the national center for palliative care ‘Agora’ (Ebenau et al., 2018). The most recent example of 
innovative practice is the supervised home detoxification model, delivered by a mobile multi-
disciplinary team (addiction physician, addictions nurse specialist (MANP)) who visit the client at home 




There is evidence to suggest that nurses in the UK have been working with problematic substance use 
for over six decades, from nursing on the first in patient addiction treatment units for alcohol 
dependency in 1955, to reports of 100-150 nurses being appointed to newly created posts to support 
regional services for the treatment of drug dependency in the early 1960s, often referred to as ‘DDUs’ 
(Drug Dependency Units).   Early roles and scope of practice have been well described (Rassool & 
Gafoor, 1997) and over the succeeding years, as services increased (primarily within the NHS system) 
so too did the numbers of nurses.  By 1986 numbers had reached a critical mass to facilitate 
establishing a special interest group called The Association of Nurses in Substance Abuse (ANSA).  In 
1997 with funding from the Department of Health, ANSA published their ‘scope of practice document’ 
outlining the role of the nurse in respect of specialist assessment, management and care of individuals 
with problematic use of psychoactive substances (licit and illicit) (Clancy, 1997).  At that time addiction 
nurses were working across a range of services including traditional hospital clinics and wards and 
community locations, such as police custody suites, primary care settings and needle exchange 
facilities.    
 
Over subsequent years, and in conjunction with unprecedented levels of change to funding, 
commissioning, management and delivery structures across the addiction treatment landscape, 
driven at the time by what many viewed as the introduction of ideological competitive tendering by 
the Government,  which witnessed the rapid shift of provision from established NHS addiction clinical 
services to third sector charities who were ‘winning’ tenders (often at reduced prices) overseen by 
local commissioning authorities.  Whilst it would be unsafe to pre-suppose that the ‘treatment 
efficacy’ provided by the new providers would be any better or worse, what this shift did result in was 
a change in the profile of the addiction workforce.  In the past decade and given that nurses are more 
strongly aligned to work within the NHS, the number of nurses working in third sector addiction 
services (which make up the largest share of service provision) are not as evident.   This has had a 
 
 
knock-on effect such that the merits of having a nurse working within an addiction service have all but 
been lost.  In 2017 members of ANSA, along with the Royal College of Nursing (RCN) were invited by 
Public Health England to set up a steering group to publish The Role of Nurses in Alcohol and Drug 
Treatment Services:  A resource for commissioners, providers and clinicians (Public Health England, 
2017).  This publication revisits and sets out the key behaviours, skills, and competencies that nurses 
offer in the care and treatment of individuals with problematic substance use.     
 
Despite these challenges addiction nurses within the UK have continued to develop and enhance their 
role and have taken advantage of the broader changes within nursing including extension to 
prescriptive authority.  Since May 2006, qualified nurses (along with pharmacists) have been 
permitted to prescribe independently, any licenced medicine for any medical condition, including 
come controlled drugs.  This enhanced role has expanded opportunities for developing the role of 
addiction nurses across services, supporting the wider multidisciplinary team, whilst increasing access 
and continuity of care for clients who require substitution programme.    In addition to clinical practice, 
addiction nurses can be found working within education (e.g. nursing schools); and research 
institutions.    
 
With respect to preparation of the ‘specialist’ addiction nurse in the UK, due to increasingly limited 
availability of post graduate training, the gradual erosion of specific addiction courses for nurses and 
the move towards multi professional/interdisciplinary cross training programmes, it could be argued 
that formal role preparation for addiction nursing is in crisis.   Notwithstanding the availability of the 
CARN and CARN-AP, these certifications primarily meet the needs of nurses working within North 
America and the curricula has been mapped accordingly.   There are some excellent training courses 
available in the UK but they are not nursing specific. Consideration on how best to address this 
educational gap, and more importantly a recognised certification in Europe remains a challenge, and 
worthy of IntNSA Europe’s attention.    
 
The ‘hidden’ role of addiction nursing in Europe 
 
Despite clear evidence that addictions nurses are employed across the European state, there is no 
workforce data available on numbers working either directly or indirectly with problematic substance 
use.  Hence any information on actual numbers of nurses, their educational preparation and their 
scope of practice is one of conjecture. However, the authors in preparing this article, in addition to 
drawing on their personal experience and research as addiction nurses which stretch across 10 – 25 
 
 
years (Clancy, Kelly, & Loth, 2018; Clancy, Oyefeso, & Ghodse, 2007; Kelly, Hegarty, Barry, Dyer, & 
Horgan, 2017; Loth et al., 2007) have engaged with key informants from 5 European countries 
(Albania, Belgium, The Netherlands, Republic of Ireland, and United Kingdom) and reviewed the 
nursing literature on role of addiction nurses, with the purpose of capturing an overview of what is 
the ‘state of the art of addiction nursing’ in 2018 in Europe.  Based on this, Table 2 provides a brief 
overview of the best available estimates of the state of addictions nursing workforce in five EU 
countries.   
 
 
Insert Table 2 here  
 
Scope of Preparation and Practice  
 
In exploring the scope and practice of addiction nursing, key informants advised that there is no 
consensus on definition of what an addictions nursing role covers in their respective countries.  This 
was also reflected in lack of clear career pathways. As noted earlier there is no workforce data 
available on numbers of addiction nurses, or indeed levels of expertise.  All informants advised that 
there is no formal set of standardized qualifications to actively differentiate daily practice in addiction 
treatment services and accredited training is noticeably absent. Whilst the role of the addictions nurse 
is not clearly defined, informants do report that nurses can be found working across a range of 
addictions treatment facilities and settings (Table 3).  An extra and positive development is the work 
of addictions nurses within primary care settings working alongside general practitioners, and for 
some countries the expansion of ‘specialist roles’ extending to midwifery.  
 
 




Despite the paucity of data providing a coherent overview of the role of addiction nurses, a review of 
the literature (including ‘grey literature) tells another, albeit modest, story.   We identified a number 
of exemplars which provide insights on the role of addiction nursing in Europe (see Table 4).  In 
addition to these exemplars there have been two studies that describe specifically the role 
development of addiction nurses, both within the UK.  The first published by the Effective 
Interventions Unit, is an exploration of the role of substance misuse nurses in Scotland (Matheson et 
al, 2004); the second reports on a study by Clancy et al. (2007), within a English sample of addiction 
nurses, which explores factors influencing recruitment and retention in addiction nursing, and the 
stages and features of role acquisition and personal quality important to that role.    
 
 
   
Insert Table 4 here 
 
Of particular concern is the absence of visible and consistent provision of addictions training at both 
pre-qualifying (e.g. fundamentals, SBIRT) and post qualifying level (i.e. specialist accreditation).   If 
training is available within undergraduate nurse education (Bachelor level), anecdotal evidence 
suggests this is primarily driven by individual nursing schools and associated presence of a faculty 
member on staff who has training or an interest in the subject of addictions, and students’ attendance 
is optional.  Key informants report that to progress and undertake advanced training as a ‘specialist 
addiction nurse’ there is no standard qualification either within country or across Europe.  Nurses who 
have attained such status undertake individualized ‘educational pathways’ which may reflect masters 
level, but this is not automatic.  The general picture is nurses choosing to take advanced practice 
courses in pharmacology (linked to prescriptive authority); and specific psychological interventions 
including for example motivational interviewing; and/or additional non-clinical academic courses on 
subjects such as dual diagnosis, substance misuse etc. to supplement on the job training within 
addiction services.   
 
Of note when informants were invited to consider what in their view were the top priorities that 
needed attention within their respective countries; the issue of addressing persistent ‘negative 
stigma’ and reinforcing the notion of the role of the wider community within the recovery agenda for 




Despite the differences (i.e. economic, political, strategic) between each country, key themes also 
highlight clear commonalties: the absence of a consensus on role definition (what does it mean to be 
an addiction nurse), standard qualifications and accreditation, lack of cogent standards and scope of 
practice; no workforce data; limited research on the role and impact of; and by addictions nurses.    
 
 
What next for European Addiction Nursing  
 
As the phenomenon of addiction continues to grip the global community, the nursing profession has 
a key role to play as one element of a response framework in preventing, reducing, and eliminating 
the harm caused by substance misuse. Indeed, this assertion was made by World Health Organisation 
(WHO) and the International Council of Nursing (ICN) when they defined the component roles of the 
nurse in relation to working with substance misuse as: provider of care, educator/resource person, 
counsellor/therapist, advocate, health promoter, researcher, supervisor/leader and consultant 
(WHO/ICN,1991).   It is discouraging that despite this proclamation over 25 years ago, the opportunity 
for this role to be fully realised across Europe is still in abeyance.   With the formal launch of IntNSA’s 
European Region in 2018 there is a real sense of energy, commitment and community of practice.   
This platform offers, for the first time, a significant opportunity for addictions nurses to come together 
with a collective purpose.   Key areas of work include: 
 
• Fighting ‘stigma’ and raising awareness; 
• Focusing on ‘recovery’; and working with emerging groups e.g. older drug users; 
• Developing and strengthening nursing expertise and explicit nursing interventions on 
addiction;  
• Positioning addiction education within ‘prequalifying’ nursing courses (i.e. preparing the next 
workforce generation); and  
• Seeking to develop, establish and gain recognition for the accreditation and certification of 
specialist addiction nurses (e.g. CARN and CARN-AP Europe)   
• Designing the scope and standards for nursing addiction across Europe 
• Developing clear career pathways and addressing pay and conditions 
 
The power of nursing is through professional coalition - the collective voice is needed now more than 
ever in Europe to shape the role of nursing in respect of addiction policy, addiction practice, addiction 
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